-
Summary
Design, synthesis and biological evaluation of novel PI3K inhibitors as antitumor agents, and the study of their mechanism of antitumor activity.
-
Achievements
-
List of Publications from the Project
-
Partners
- Prof. Dexin Kong, School of Pharmacy, Tianjin Medical University
-
Project Members
-
Project Leaders
-
Project PI
-
Faculty
Faculty of Pharmacy
-
Research Group
-
Funding Agency
STDF / STIFA
-
Funding Program
Egypt-China Cooperation
-
Start Date
2026-06-04
-
End Date
2029-06-04
-
Sustainable Development Goals (SDGs)
- 3: Good Health and Well-being
- 17: Partnerships to achieve the Goal
-
Project website